Lexeo Therapeutics Inc (LXEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 22,333 | 23,116 | 21,648 | 30,688 | 33,805 |
| Operating Income | -22,333 | -23,116 | -21,648 | -30,688 | -33,805 |
| Interest Expense | 17 | 20 | 22 | 25 | 28 |
| Other Income | 2,154 | 2,217 | 1,387 | 4,610 | 1,177 |
| Pre-tax Income | -20,196 | -20,919 | -20,283 | -26,103 | -32,656 |
| Net Income Continuous | -20,196 | -20,919 | -20,283 | -26,103 | -32,656 |
| Net Income | $-20,196 | $-20,919 | $-20,283 | $-26,103 | $-32,656 |
| EPS Basic Total Ops | -0.25 | 0.06 | -0.33 | -0.60 | -0.99 |
| EPS Basic Continuous Ops | -0.25 | 0.05 | -0.33 | -0.60 | -0.99 |
| EPS Diluted Total Ops | -0.25 | 0.06 | -0.33 | -0.60 | -0.99 |
| EPS Diluted Continuous Ops | -0.25 | 0.05 | -0.33 | -0.60 | -0.99 |
| EPS Diluted Before Non-Recurring Items | -0.25 | -0.27 | -0.33 | -0.60 | -0.99 |
| EBITDA(a) | $-22,302 | $-23,038 | $-21,515 | $-30,592 | $-33,733 |